Literature DB >> 15557605

Resistance of Mycoplasma pulmonis to complement lysis is dependent on the number of Vsa tandem repeats: shield hypothesis.

Warren L Simmons1, Amy M Denison, Kevin Dybvig.   

Abstract

The Vsa proteins are associated with the virulence of the murine respiratory pathogen Mycoplasma pulmonis. The antigens consist of a conserved N-terminal region that is combined with one of several different variable C-terminal regions comprised of tandem repeats. M. pulmonis strains that produce VsaA with about 40 tandem repeats do not adhere to polystyrene or erythrocytes and are highly resistant to complement killing. Strains that produce VsaA with three tandem repeats adhere strongly to polystyrene and erythrocytes and are highly susceptible to complement killing. We report here that the resistance to complement lysis was not due to a lack of activation of the complement cascade. Isolation and analysis of M. pulmonis strains that produced Vsa proteins other than VsaA (VsaG and VsaI) with either long or short repeat regions indicated that adherence to polystyrene and resistance to complement were dependent on the length of the repeat region but not on the Vsa type. Furthermore, M. pulmonis Vsa variants were susceptible to the polypeptide pore-forming molecule gramicidin D, independent of the Vsa type and length. Collectively, the data indicate the Vsa proteins nonspecifically mediate M. pulmonis surface interactions and function to sterically hinder access of complement to the mycoplasma cell membrane while permitting access of smaller molecules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557605      PMCID: PMC529130          DOI: 10.1128/IAI.72.12.6846-6851.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Gene rearrangements in the vsa locus of Mycoplasma pulmonis.

Authors:  X Shen; J Gumulak; H Yu; C T French; N Zou; K Dybvig
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

2.  Gene transfer in Mycoplasma pulmonis.

Authors:  Amy M Teachman; C Todd French; Huilan Yu; Warren L Simmons; Kevin Dybvig
Journal:  J Bacteriol       Date:  2002-02       Impact factor: 3.490

Review 3.  Structure and biology of complement protein C3, a connecting link between innate and acquired immunity.

Authors:  A Sahu; J D Lambris
Journal:  Immunol Rev       Date:  2001-04       Impact factor: 12.988

4.  Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H.

Authors:  C Neeleman; S P Geelen; P C Aerts; M R Daha; T E Mollnes; J J Roord; G Posthuma; H van Dijk; A Fleer
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Variations in the surface proteins and restriction enzyme systems of Mycoplasma pulmonis in the respiratory tract of infected rats.

Authors:  J Gumulak-Smith; A Teachman; A H Tu; J W Simecka; J R Lindsey; K Dybvig
Journal:  Mol Microbiol       Date:  2001-05       Impact factor: 3.501

6.  Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma.

Authors:  C L Karp; A Grupe; E Schadt; S L Ewart; M Keane-Moore; P J Cuomo; J Köhl; L Wahl; D Kuperman; S Germer; D Aud; G Peltz; M Wills-Karp
Journal:  Nat Immunol       Date:  2000-09       Impact factor: 25.606

7.  Construction and use of derivatives of transposon Tn4001 that function in Mycoplasma pulmonis and Mycoplasma arthritidis.

Authors:  K Dybvig; C T French; L L Voelker
Journal:  J Bacteriol       Date:  2000-08       Impact factor: 3.490

8.  Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to membrane-active peptides and enrofloxacin in human tissue cell cultures.

Authors:  Ran Nir-Paz; Marie-Christine Prévost; Pierre Nicolas; Alain Blanchard; Henri Wróblewski
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

9.  Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation.

Authors:  A Alitalo; T Meri; L Rämö; T S Jokiranta; T Heikkilä; I J Seppälä; J Oksi; M Viljanen; S Meri
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

10.  Complement factor 3 mediates particulate matter-induced airway hyperresponsiveness.

Authors:  Dianne M Walters; Patrick N Breysse; Brian Schofield; Marsha Wills-Karp
Journal:  Am J Respir Cell Mol Biol       Date:  2002-10       Impact factor: 6.914

View more
  17 in total

1.  Resistance to antimicrobial peptides and stress response in Mycoplasma pulmonis.

Authors:  Lina Fassi Fehri; Pascal Sirand-Pugnet; Géraldine Gourgues; Gwenaël Jan; Henri Wróblewski; Alain Blanchard
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

2.  Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

3.  Occurrence, plasticity, and evolution of the vpma gene family, a genetic system devoted to high-frequency surface variation in Mycoplasma agalactiae.

Authors:  Laurent-Xavier Nouvel; Marc Marenda; Pascal Sirand-Pugnet; Eveline Sagné; Michelle Glew; Sophie Mangenot; Valérie Barbe; Aurélien Barré; Stéphane Claverol; Christine Citti
Journal:  J Bacteriol       Date:  2009-04-17       Impact factor: 3.490

4.  Large-scale transposon mutagenesis of Mycoplasma pulmonis.

Authors:  Christopher T French; Ping Lao; Ann E Loraine; Brian T Matthews; Huilan Yu; Kevin Dybvig
Journal:  Mol Microbiol       Date:  2008-04-28       Impact factor: 3.501

5.  Mycoplasma pulmonis Vsa proteins and polysaccharide modulate adherence to pulmonary epithelial cells.

Authors:  Jeffrey R Bolland; Kevin Dybvig
Journal:  FEMS Microbiol Lett       Date:  2012-04-10       Impact factor: 2.742

6.  Catalase Enhances Growth and Biofilm Production of Mycoplasma pneumoniae.

Authors:  Warren L Simmons; Kevin Dybvig
Journal:  Curr Microbiol       Date:  2015-04-18       Impact factor: 2.188

7.  A stochastic mechanism for biofilm formation by Mycoplasma pulmonis.

Authors:  Warren L Simmons; Jeffrey R Bolland; James M Daubenspeck; Kevin Dybvig
Journal:  J Bacteriol       Date:  2006-12-01       Impact factor: 3.490

8.  Distinctive repertoire of contingency genes conferring mutation- based phase variation and combinatorial expression of surface lipoproteins in Mycoplasma capricolum subsp. capricolum of the Mycoplasma mycoides phylogenetic cluster.

Authors:  Kim S Wise; Mark F Foecking; Kerstin Röske; Young Jin Lee; Young Moo Lee; Anup Madan; Michael J Calcutt
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

9.  Mycoplasma polysaccharide protects against complement.

Authors:  Jeffrey R Bolland; Warren L Simmons; James M Daubenspeck; Kevin Dybvig
Journal:  Microbiology       Date:  2012-04-13       Impact factor: 2.777

10.  The Vsa shield of Mycoplasma pulmonis is antiphagocytic.

Authors:  Brandon M Shaw; Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.